A major breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage mutated p53. This essential cancer suppressor protein is frequently disabled in several types of malignancies, leading https://mnobookmarks.com/story21849110/mini-antibodies-reactivate-the-p53-protein-new-promising-hope-for-malignant-management